The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios
View ORCID ProfileGeorge Ng, Constance Wang
doi: https://doi.org/10.1101/2020.04.21.20074070
George Ng
1University of California, Berkeley, School of Public Health
2University of California, Berkeley, College of Engineering
PhDConstance Wang
1University of California, Berkeley, School of Public Health
PhD
Posted April 26, 2020.
The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios
George Ng, Constance Wang
medRxiv 2020.04.21.20074070; doi: https://doi.org/10.1101/2020.04.21.20074070
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (715)
- Anesthesia (209)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12872)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4667)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2969)
- Health Policy (1079)
- Hematology (394)
- HIV/AIDS (941)
- Medical Education (433)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4449)
- Nursing (239)
- Nutrition (654)
- Oncology (2316)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (329)
- Pain Medicine (287)
- Palliative Medicine (85)
- Pathology (505)
- Pediatrics (1207)
- Primary Care Research (506)
- Public and Global Health (7047)
- Radiology and Imaging (1563)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)